ANTONIA CALABRO-PAYNE: Open Payments
NPI 1528284460 · BLAIRSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$354 in 12 payments from 8 companies in 2025. Trend: 2023 $50 · 2024 $0 · 2025 $354
Food & beverage: $354
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $95 |
| Edwards Lifesciences Corporation | 2 | $72 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| PFIZER INC. | 2 | $33 |
| Alnylam Pharmaceuticals Inc. | 1 | $32 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $17 |
Products named: CARDIOMEMS, SAPIEN 3 Ultra RESILIA, VERQUVO, LEQVIO, VYNDAQEL, AMVUTTRA, OPSUMIT, NEXLETOL.
Industry payments across GA — which companies pay providers there.
